Results 191 to 200 of about 21,301 (244)

Nomogram for predicting post-transarterial chemoembolization survival in recurrent patients with hepatitis B virus-associated hepatocellular carcinoma. [PDF]

Sci Rep
Guo ZY, Tu MY, Yang YS, Xu LX, Fan DD.
europepmc   +1 more source

Predictive Modeling and Mendelian Randomization for Identifying HCC Patients with High Response to TACE with Atezolizumab and Bevacizumab. [PDF]

J Hepatocell Carcinoma
Chen W, Liu J, Chen S, Li S, Shi K, Xia R, Shi Y, Tan J, Lin N.   +8 more
europepmc   +1 more source

Gamma-glutamyltransferase and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta‑analysis and systematic review. [PDF]

BMC Gastroenterol
Huang Z, Zhou M, Feng S, Xiao X, Zhong B.   +4 more
europepmc   +1 more source

Efficacy and safety of CalliSpheres drug-eluting bead bronchial arterial infusion chemoembolization vs. bland embolization in advanced lung cancer with hemoptysis: A multicenter retrospective study. [PDF]

Biomol Biomed
Liu S, Yin M, Liu S, Xu H, Yu G, Liu X, Chen G, Zhang W.   +7 more
europepmc   +1 more source

Arterial and biliary complications after transarterial chemoembolization for hepatocellular carcinoma. [PDF]

World J Clin Oncol
Wan YX, Lin ZY, Chen LT, Wu RQ, Zhang Y, Du ZQ.   +5 more
europepmc   +1 more source

A machine learning approach to identify optimal candidates for transarterial chemoembolization in unresectable HBV-related hepatocellular carcinoma complicated by first-branch portal vein tumor thrombus: a multicenter study. [PDF]

Front Oncol
Zhao S, Zhang Q, Tang Y, Wang Y, Song J, Han T, Zhao H, Zhang Y, Yuan C, Li X, Zhu J, Zhao L.   +11 more
europepmc   +1 more source

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma.

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma.
openaire  

Some of the next articles are maybe not open access.

Related searches:

Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

CardioVascular and Interventional Radiology, 2022
To evaluate the preclinical in vivo therapeutic response of Lenvatinib-eluting microspheres (LEN-EM) transcatheter arterial chemoembolization (LEN-TACE) in an hepatocellular carcinoma (HCC) rat model.Magnetic resonance imaging (MRI) visible LEN-EM was fabricated with poly(lactide-co-glycolide) and iron oxide nanoparticles by a double-emulsion method ...
Jason Pe, Bongseo Choi, Hyunjun Choi, Soon Woo Kwon, Dong-Hyun Kim   +4 more
openaire   +2 more sources

Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization

Radiology, 2023
Background Hepatocellular carcinomas (HCCs) can be divided into proliferative and nonproliferative types, which may have implications for outcomes after conventional transarterial chemoembolization (cTACE). Biopsy to identify proliferative HCC is not routinely performed before cTACE.
Yan Bao, Jun-Xiang Li, Peng Zhou, Yao Tong, Li-Zhou Wang, De-Hua Chang, Wen-Wu Cai, Lu Wen, Jun Liu, Yu-Dong Xiao   +9 more
openaire   +2 more sources